These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of topiramate in treatment-resistant bipolar spectrum disorders. Vieta E; Torrent C; Garcia-Ribas G; Gilabert A; Garcia-Parés G; Rodriguez A; Cadevall J; García-Castrillón J; Lusilla P; Arrufat F J Clin Psychopharmacol; 2002 Aug; 22(4):431-5. PubMed ID: 12172346 [TBL] [Abstract][Full Text] [Related]
5. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. McIntyre RS; Mancini DA; McCann S; Srinivasan J; Sagman D; Kennedy SH Bipolar Disord; 2002 Jun; 4(3):207-13. PubMed ID: 12180276 [TBL] [Abstract][Full Text] [Related]
6. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR; J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048 [TBL] [Abstract][Full Text] [Related]
8. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [TBL] [Abstract][Full Text] [Related]
9. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Chengappa KN; Gershon S; Levine J Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders. Barzman DH; DelBello MP; Kowatch RA; Warner J; Rofey D; Stanford K; Rappaport K; Daniels JP; Strakowski SM J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):931-7. PubMed ID: 16379513 [TBL] [Abstract][Full Text] [Related]
11. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842 [TBL] [Abstract][Full Text] [Related]
12. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Kushner SF; Khan A; Lane R; Olson WH Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977 [TBL] [Abstract][Full Text] [Related]
13. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978 [TBL] [Abstract][Full Text] [Related]
14. Open-label adjunctive topiramate in the treatment of unstable bipolar disorder. McIntyre RS; Riccardelli R; Binder C; Kusumakar V Can J Psychiatry; 2005 Jun; 50(7):415-22. PubMed ID: 16086539 [TBL] [Abstract][Full Text] [Related]
15. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588 [TBL] [Abstract][Full Text] [Related]
16. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. Maina G; Albert U; Salvi V; Mancini M; Bogetto F J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122 [TBL] [Abstract][Full Text] [Related]
17. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953 [TBL] [Abstract][Full Text] [Related]
18. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up. Karama S; Lal S Eur Psychiatry; 2006 Jun; 21(4):280-1. PubMed ID: 16360310 [TBL] [Abstract][Full Text] [Related]
20. 1-year follow-up of patients treated with risperidone and topiramate for a manic episode. Vieta E; Goikolea JM; Olivares JM; González-Pinto A; Rodriguez A; Colom F; Comes M; Torrent C; Sánchez-Moreno J J Clin Psychiatry; 2003 Jul; 64(7):834-9. PubMed ID: 12934986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]